An Abbott (NYSE:ABT) official has shared a significant reimbursement win for its Esprit BTK drug-eluting scaffold system.

Despite major advances in targeted therapy, chronic lymphocytic leukemia (CLL) remains largely incurable. Resistance to ...

Abbott announced that its transcatheter Esprit below-the-knee (BTK) everolimus-eluting resorbable scaffold system has been ...

My Father the BTK Killer Review: It shifts the focus from the perpetrator to those whose life the BTK killer destroyed and ...

ORLANDO -- Patients with newly diagnosed chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) lived significantly longer without disease progression when treated with the Bruton's ...

• BTK inhibitors work by targeting and blocking the BTK enzyme, which is crucial for the survival and growth of cancerous B-cells in mantle cell lymphoma (MCL). This cuts off the cancer cell’s support ...

A review article examines questions about sequencing treatments in light of recent developments in relapsed/refractory mantle cell lymphoma. Treatment approaches have shifted with the introduction of ...

The FDA has granted traditional approval to brexucabtagene autoleucel (Tecartus; brexu-cel) for treatment of adult patients ...

Add Yahoo as a preferred source to see more of our stories on Google. Newsmax host Greg Kelly tries to compare BTK serial killer Dennis Rader (right) to Alex Pretti (center), as part of a far-right ...